Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 15-Nov-24 4:30 PM View:  | Saha Saurabh Chief Executive Officer Director | Centessa Pharmaceuticals Plc (CNTA) | 13-Nov-24 | Option Exercise | 32,023 | $5.84 | $187,014.00 | 5% 668.66K to 700.68K | |
| 15-Nov-24 4:30 PM View: | Saha Saurabh Chief Executive Officer Director | Centessa Pharmaceuticals Plc (CNTA) | 13-Nov-24 | Planned Option Sale | 32,023 | $18.28 | $585,419.00 | (5%) 700.68K to 668.66K | |
| 02-Oct-24 4:33 PM View: | Chao David M Chief Administrative Officer | Centessa Pharmaceuticals Plc (CNTA) | 30-Sep-24 | Payment of Exercise | 10,385 | $15.79 | $163,979.00 | (4%) 262.6K to 252.22K | |
| 27-Sep-24 4:15 PM View: | Weinhoff Gregory M Chief Business Officer | Centessa Pharmaceuticals Plc (CNTA) | 25-Sep-24 | Private Sale (Planned) | 16,619 | $15.69 | $260,724.00 | (7%) 223.37K to 206.75K | |
| 20-Sep-24 4:55 PM View: | Saha Saurabh Chief Executive Officer Director | Centessa Pharmaceuticals Plc (CNTA) | 20-Sep-24 | Private Sale (Planned) | 55,000 | $16.53 | $908,985.00 | (7%) 814.92K to 759.92K | |
| 12-Sep-24 8:01 PM View: | Weinhoff Gregory M Chief Business Officer | Centessa Pharmaceuticals Plc (CNTA) | 10-Sep-24 | Planned Option Sale | 30,000 | $17.00 | $510,000.00 | (12%) 253.37K to 223.37K | |
| 12-Sep-24 8:01 PM View: | Saha Saurabh Chief Executive Officer Director | Centessa Pharmaceuticals Plc (CNTA) | 10-Sep-24 | Planned Option Sale | 175,000 | $16.52 | $2,891,820.00 | (18%) 989.92K to 814.92K | |
| 12-Sep-24 8:01 PM View: | Saha Saurabh Chief Executive Officer Director | Centessa Pharmaceuticals Plc (CNTA) | 10-Sep-24 | Option Exercise | 175,000 | $5.84 | $1,022,000.00 | 21% 814.92K to 989.92K | |
| 12-Sep-24 8:01 PM View: | Weinhoff Gregory M Chief Business Officer | Centessa Pharmaceuticals Plc (CNTA) | 10-Sep-24 | Option Exercise | 30,000 | $5.84 | $175,200.00 | 13% 223.37K to 253.37K | |
| 09-Sep-24 5:06 PM View: | Weinhoff Gregory M Chief Business Officer | Centessa Pharmaceuticals Plc (CNTA) | 09-Sep-24 | Option Exercise | 25,000 | $5.84 | $146,000.00 | 11% 223.37K to 248.37K | |
| 09-Sep-24 5:06 PM View: | Weinhoff Gregory M Chief Business Officer | Centessa Pharmaceuticals Plc (CNTA) | 09-Sep-24 | Planned Option Sale | 25,000 | $15.00 | $375,000.00 | (10%) 248.37K to 223.37K | |
| 23-Aug-24 5:13 PM View: | Saha Saurabh Chief Executive Officer Director | Centessa Pharmaceuticals Plc (CNTA) | 23-Aug-24 | Private Sale (Planned) | 46,651 | $12.30 | $573,905.00 | (5%) 861.58K to 814.92K | |
| 23-Aug-24 5:12 PM View: | Weinhoff Gregory M Chief Business Officer | Centessa Pharmaceuticals Plc (CNTA) | 23-Aug-24 | Sale (Planned) | 17,802 | $12.29 | $218,792.00 | (7%) 241.17K to 223.37K | |
| 23-Aug-24 5:12 PM View: | Weinhoff Gregory M Chief Business Officer | Centessa Pharmaceuticals Plc (CNTA) | 22-Aug-24 | Private Sale (Planned) | 12,198 | $12.17 | $148,430.00 | (5%) 253.37K to 241.17K | |
| 22-Aug-24 5:15 PM View: | Saha Saurabh Chief Executive Officer Director | Centessa Pharmaceuticals Plc (CNTA) | 22-Aug-24 | Sale (Planned) | 506 | $12.23 | $6,188.38 | (< 1%) 862.08K to 861.58K | |
| 22-Aug-24 5:15 PM View: | Saha Saurabh Chief Executive Officer Director | Centessa Pharmaceuticals Plc (CNTA) | 21-Aug-24 | Sale (Planned) | 3,674 | $12.25 | $44,989.20 | (< 1%) 865.75K to 862.08K | |
| 22-Aug-24 5:15 PM View: | Saha Saurabh Chief Executive Officer Director | Centessa Pharmaceuticals Plc (CNTA) | 20-Aug-24 | Private Sale (Planned) | 4,169 | $12.32 | $51,368.30 | (< 1%) 869.92K to 865.75K | |
| 02-Apr-24 4:18 PM View: | Weinhoff Gregory M Chief Financial Officer | Centessa Pharmaceuticals Plc (CNTA) | 31-Mar-24 | Payment of Exercise | 11,742 | $11.30 | $132,685.00 | (4%) 276.85K to 265.11K | |
| 02-Apr-24 4:15 PM View: | Bush Tia L Chief Technology & Quality Ofc | Centessa Pharmaceuticals Plc (CNTA) | 31-Mar-24 | Payment of Exercise | 6,419 | $11.30 | $72,534.70 | (4%) 176.48K to 170.06K | |
| 02-Apr-24 4:16 PM View: | Hussain Iqbal J General Counsel | Centessa Pharmaceuticals Plc (CNTA) | 31-Mar-24 | Payment of Exercise | 7,520 | $11.30 | $84,976.00 | (3%) 225.55K to 218.03K | |
| 02-Apr-24 4:17 PM View: | Saha Saurabh Chief Executive Officer Director | Centessa Pharmaceuticals Plc (CNTA) | 31-Mar-24 | Payment of Exercise | 36,263 | $11.30 | $409,772.00 | (4%) 942.45K to 906.19K | |
| 02-Apr-24 4:19 PM View: | Chao David M Chief Administrative Officer | Centessa Pharmaceuticals Plc (CNTA) | 31-Mar-24 | Payment of Exercise | 10,385 | $11.30 | $117,350.00 | (4%) 283.37K to 272.99K | |
| 26-Mar-24 4:16 PM View: | Anderson Karen M. Chief People Officer | Centessa Pharmaceuticals Plc (CNTA) | 25-Mar-24 | Sale (Planned) | 6,160 | $11.88 | $73,202.40 | (8%) 77.69K to 71.53K | |
| 26-Mar-24 4:16 PM View: | Anderson Karen M. Chief People Officer | Centessa Pharmaceuticals Plc (CNTA) | 25-Mar-24 | Option Exercise | 45,000 | $3.94 | $177,252.00 | 58% 77.69K to 122.69K | |
| 26-Mar-24 4:16 PM View: | Anderson Karen M. Chief People Officer | Centessa Pharmaceuticals Plc (CNTA) | 25-Mar-24 | Planned Option Sale | 45,000 | $11.88 | $534,758.00 | (37%) 122.69K to 77.69K | |
| 02-Feb-24 5:08 PM View: | Weinhoff Gregory M Chief Financial Officer | Centessa Pharmaceuticals Plc (CNTA) | 01-Feb-24 | Grant | 31,250 | -- | -- | 12% 257.1K to 288.35K | |
| 02-Feb-24 5:02 PM View: | Anderson Karen M. Chief People Officer | Centessa Pharmaceuticals Plc (CNTA) | 01-Feb-24 | Payment of Exercise | 7,265 | $8.19 | $59,500.30 | (9%) 84.95K to 77.69K | |
| 02-Feb-24 5:03 PM View: | Rotman Harris SVP Regulatory Affairs | Centessa Pharmaceuticals Plc (CNTA) | 01-Feb-24 | Grant | 37,500 | -- | -- | 112% 33.5K to 71.0K | |
| 02-Feb-24 5:09 PM View: | Hussain Iqbal J General Counsel | Centessa Pharmaceuticals Plc (CNTA) | 01-Feb-24 | Grant | 42,500 | -- | -- | 22% 190.94K to 233.44K | |
| 02-Feb-24 5:07 PM View: | Saha Saurabh Chief Executive Officer Director | Centessa Pharmaceuticals Plc (CNTA) | 01-Feb-24 | Grant | 144,200 | -- | -- | 17% 824.57K to 968.77K | |
| 02-Feb-24 5:10 PM View: | Chao David M Chief Administrative Officer | Centessa Pharmaceuticals Plc (CNTA) | 01-Feb-24 | Payment of Exercise | 9,503 | $8.19 | $77,829.60 | (3%) 292.87K to 283.37K | |
| 02-Feb-24 5:03 PM View: | Rotman Harris SVP Regulatory Affairs | Centessa Pharmaceuticals Plc (CNTA) | 01-Feb-24 | Payment of Exercise | 4,108 | $8.19 | $33,644.50 | (6%) 71.0K to 66.89K | |
| 02-Feb-24 5:04 PM View: | Bush Tia L Chief Quality Officer | Centessa Pharmaceuticals Plc (CNTA) | 01-Feb-24 | Payment of Exercise | 3,862 | $8.19 | $31,629.80 | (2%) 180.34K to 176.48K | |
| 02-Feb-24 5:10 PM View: | Chao David M Chief Administrative Officer | Centessa Pharmaceuticals Plc (CNTA) | 01-Feb-24 | Grant | 37,500 | -- | -- | 15% 255.37K to 292.87K | |
| 02-Feb-24 5:08 PM View: | Weinhoff Gregory M Chief Financial Officer | Centessa Pharmaceuticals Plc (CNTA) | 01-Feb-24 | Payment of Exercise | 11,494 | $8.19 | $94,135.90 | (4%) 288.35K to 276.85K | |
| 02-Feb-24 5:02 PM View: | Anderson Karen M. Chief People Officer | Centessa Pharmaceuticals Plc (CNTA) | 01-Feb-24 | Grant | 31,250 | -- | -- | 58% 53.7K to 84.95K | |
| 02-Feb-24 5:03 PM View: | Rotman Harris SVP Regulatory Affairs | Centessa Pharmaceuticals Plc (CNTA) | 01-Feb-24 | Sale (Planned) | 4,267 | $8.10 | $34,574.20 | (6%) 66.89K to 62.63K | |
| 02-Feb-24 5:09 PM View: | Hussain Iqbal J General Counsel | Centessa Pharmaceuticals Plc (CNTA) | 01-Feb-24 | Payment of Exercise | 7,885 | $8.19 | $64,578.10 | (3%) 233.44K to 225.55K | |
| 02-Feb-24 5:07 PM View: | Saha Saurabh Chief Executive Officer Director | Centessa Pharmaceuticals Plc (CNTA) | 01-Feb-24 | Payment of Exercise | 26,323 | $8.19 | $215,585.00 | (3%) 968.77K to 942.45K | |
| 02-Feb-24 5:04 PM View: | Bush Tia L Chief Quality Officer | Centessa Pharmaceuticals Plc (CNTA) | 01-Feb-24 | Grant | 42,500 | -- | -- | 31% 137.84K to 180.34K | |
| 02-Jan-24 7:46 PM View: | Chao David M Chief Administrative Officer | Centessa Pharmaceuticals Plc (CNTA) | 31-Dec-23 | Payment of Exercise | 10,419 | $7.96 | $82,935.20 | (4%) 265.79K to 255.37K | (13%) |
| 02-Jan-24 7:37 PM View: | Bush Tia L Chief Quality Officer | Centessa Pharmaceuticals Plc (CNTA) | 31-Dec-23 | Payment of Exercise | 6,419 | $7.96 | $51,095.20 | (4%) 144.26K to 137.84K | (13%) |
| 02-Jan-24 7:45 PM View: | Weinhoff Gregory M Chief Financial Officer | Centessa Pharmaceuticals Plc (CNTA) | 31-Dec-23 | Payment of Exercise | 11,742 | $7.96 | $93,466.30 | (4%) 268.84K to 257.1K | (13%) |
| 02-Jan-24 7:41 PM View: | Grainger David J Chief Innovation Officer | Centessa Pharmaceuticals Plc (CNTA) | 31-Dec-23 | Payment of Exercise | 4,700 | $7.96 | $37,412.00 | (< 1%) 994.99K to 990.29K | (13%) |
| 02-Jan-24 7:44 PM View: | Hussain Iqbal J General Counsel | Centessa Pharmaceuticals Plc (CNTA) | 31-Dec-23 | Payment of Exercise | 7,520 | $7.96 | $59,859.20 | (4%) 198.46K to 190.94K | (13%) |
| 02-Jan-24 7:43 PM View: | Saha Saurabh Chief Executive Officer Director | Centessa Pharmaceuticals Plc (CNTA) | 31-Dec-23 | Payment of Exercise | 36,263 | $7.96 | $288,653.00 | (4%) 860.84K to 824.57K | (13%) |
| 03-Oct-23 4:59 PM View: | Grainger David J Chief Innovation Officer | Centessa Pharmaceuticals Plc (CNTA) | 30-Sep-23 | Payment of Exercise | 4,700 | $6.47 | $30,409.00 | (< 1%) 999.69K to 994.99K | |
| 03-Oct-23 4:46 PM View: | Bush Tia L Chief Quality Officer | Centessa Pharmaceuticals Plc (CNTA) | 30-Sep-23 | Payment of Exercise | 6,419 | $6.47 | $41,530.90 | (4%) 150.68K to 144.26K | |
| 03-Oct-23 4:51 PM View: | Chao David M Chief Administrative Officer | Centessa Pharmaceuticals Plc (CNTA) | 30-Sep-23 | Payment of Exercise | 10,419 | $6.47 | $67,410.90 | (4%) 276.21K to 265.79K | |
| 03-Oct-23 4:56 PM View: | Weinhoff Gregory M Chief Financial Officer | Centessa Pharmaceuticals Plc (CNTA) | 30-Sep-23 | Payment of Exercise | 11,742 | $6.47 | $75,970.70 | (4%) 280.58K to 268.84K |
